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to have involved subfunctionalization 
and later optimization in the regula-
tory regions of GAL1 and GAL3 in the 
lineage leading to S. cerevisiae. They 
found that replacing Gal3p with Gal1p 
resulted in decreased fitness relative 
to wild-type under inducing conditions. 
In addition, this strain does much bet-
ter than a strain missing not only the 
GAL3 coding sequence but also the 
GAL3 promoter. Taken together, this 
suggests that GAL1 and GAL3 have 
also undergone subfunctionalization 
of their promoters, PGAL1 and PGAL3. As 
a result of these changes, neither pro-
moter is now a satisfactory substitute 
for the other. Expression of Gal1p from 
PGAL3 under inducing conditions is too 
low to permit efficient metabolism, and 
basal expression of Gal3p from PGAL1 
is too low to permit efficient induction. 
 PKlacGAL1 is also inferior to the modern S. 
cerevisiae PGAL1. Expression of Gal1p 
from PKlacGAL1 under inducing conditions 
is about 50% that from PGAL1, reduc-
ing fitness approximately 10%. These 
results suggest that adaptive muta-
tions have occurred in PGAL1, strength-
ening its inducibility.
To detail the molecular mechanisms 
involved in resolving the adaptive con-
flict, Hittinger and Carroll next tested 
the connection between fitness and 
the helical phasing of Gal4p binding 
sites within the S. cerevisiae and K. 
lactis GAL1 promoters. The impor-
tance of helical spacing of Gal4p bind-
ing sites in the activation of GAL1 has 
been well documented (Webster and 
Dickson, 1988). In PGAL1, the three core 
Gal4p sites are on the same side of 
the double helix; in PKlacGAL1, they are 
on alternate sides. The authors tested 
the consequences of evolutionary 
changes in the binding side (phasing) 
by modifying PKlacGAL1 to the spacing 
of PGAL1 and found that both induced 
and noninduced expression increases. 
These results suggest that the adaptive 
conflict was resolved after duplication 
by subfunctionalization of the promoter 
and later optimization of galactose 
metabolism by changes in the phasing 
in PGAL1 (Figure 1B).
The actual ecological relevance of 
these mutations remains unclear. Hit-
tinger and Carroll discovered that in 
K. lactis, the modified PKlacGAL1 outper-
forms the wild-type PKlacGAL1 at high 
galactose and lactose concentrations. 
In this species, limitations to the coin-
duction function are offset by a benefit 
to the galactokinase function. Reduced 
spacing may not be favored under the 
spectrum of conditions encountered 
by K. lactis in the wild, which could 
account for the arrangement of Gal4p 
binding sites in this species during 
100 million years of divergence from 
the common ancestor. Understanding 
how gene duplication affects fitness 
under ecologically relevant conditions 
remains an important next step for this 
and other studies that examine the evo-
lution of gene function.
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In this issue, Ajioka et al. (2007) report a new mouse model of retinoblastoma. They show 
that retinoblastoma is not driven by uncontrolled expansion of retinal progenitor cells, but 
rather is the result of cell cycle re-entry and expansion of differentiated horizontal interneu-
rons in the retina.Retinoblastoma, a rare childhood 
cancer of the retina, has intrigued 
scientists for decades. Studies of 
retinoblastoma have provided piv-otal insights into basic mechanisms 
underlying cancer formation. Retino-
blastoma has served as a key model 
for tumor development caused by Cell 131, Ocloss of tumor suppressor genes 
since the discovery of the retino-
blastoma gene RB. The retinoblas-
toma protein pRB is a central gate-tober 19, 2007 ©2007 Elsevier Inc. 227
keeper of the cell cycle governing 
the transition of cells from G1 into S 
phase. The RB protein is helped by 
two related proteins, p107 and p130, 
collectively called “pocket proteins” 
because of their characteristic pro-
tein-interaction pocket. Together, 
they act as molecular switches turn-
ing off the activity of E2F transcrip-
tion factors in response to growth-
restricting conditions. Although 
this is now textbook knowledge 
(Weinberg, 2006), the new work by 
Ajioka et al. (2007) on development 
of retinoblastoma in mice deficient 
for pocket proteins may provide 
another leap forward in our under-
standing of cancer.
Retinoblastoma was among the 
first cancers to be modeled in mice. 
However, early efforts at model-
ing retinoblastoma by targeting the 
Rb gene were a failure. Although 
children with one defective copy of 
RB invariably develop retinoblas-
toma following loss of the wild-type 
allele, no retinal abnormalities were 
observed in the corresponding 
mouse model. Instead, these ani-
mals suffered from a multiple endo-
crine neoplasia syndrome mani-
fested by development of pituitary 
and thyroid tumors in which the 
wild-type Rb allele was lost. It was 
then discovered that retinoblastoma 
development in mice required inac-
tivation of pRB plus another pocket 
protein, p107 or p130 (Robanus-
Maandag et al., 1998; Dannenberg 
et al., 2004). In p107- or p130-de-
ficient mice, removal of Rb in the 
retina (Chen et al., 2004; MacPher-
son et al., 2004; Zhang et al., 2004) 
caused formation of retinoblastoma 
tumors with a morphology resem-
bling a specific subset of retinal 
cells—the amacrine cells that are 
interneurons of the inner nuclear 
layer. However, Ajioka et al. (2007) 
now demonstrate that inactivation 
of Rb in p130−/−p107+/− mice results 
in tumors with characteristics of 
another inner nuclear layer cell type 
of the retina, horizontal cells, which 
are also interneurons.
How do retinoblastomas arise? 
Retinal development has three dis-
tinct phases. First there is expansion 228 Cell 131, October 19, 2007 ©2007 Eof progenitor cells, then cell-cycle 
exit and differentiation of these cells 
into postmitotic precursors (also 
called “transit cells”), and finally 
terminal differentiation yielding the 
seven major retinal cell types. Two 
pathways have been proposed 
for retinoblastoma development. 
First, pocket-protein ablation may 
induce unscheduled expansion of 
an undifferentiated retinal progeni-
tor cell that has retained the capac-
ity of self-renewal and differentia-
tion into specific cell types, such 
as inner nuclear layer cells (Zhang 
et al., 2004). Alternatively, tumors 
may arise from cell-cycle re-entry 
of lineage-specific, postmitotic pre-
cursor cells (Chen et al., 2004). The 
question is of interest, as it touches 
upon the heavily debated cancer 
stem cell hypothesis. If the first were 
true, the absence of pocket proteins 
would lead to increased division of 
poorly differentiated progenitors at 
the outer edge of the retina; however, 
this has not been observed (Chen et 
al., 2004). Instead, it is the second 
pathway resulting in increased pro-
liferation of differentiated precur-
sor cell types that seems to occur. 
Apparently, in the absence of pocket 
proteins, differentiation into precur-
sor cells proceeds normally despite 
continuing proliferation. However, 
these cells do not tolerate the 
absence of pocket proteins: rods, 
cones, ganglion cells, and bipolar 
cells of the retina undergo apoptotic 
cell death; in contrast, amacrine, 
horizontal, and Müller cells survive 
but stop proliferating (Chen et al., 
2004; MacPherson et al., 2004). 
As the latter cell types are found 
in full-blown retinoblastoma, it has 
been suggested (Chen et al., 2004) 
that alleviation of cell-cycle arrest 
rather than suppression of apop-
tosis is required for transformation 
of retinal cells lacking pocket pro-
teins. The scenario thus emerging is 
that retinoblastoma in mice results 
from cell-cycle re-entry and subse-
quent proliferation of an intrinsically 
death-resistant precursor cell.
The new work by Ajioka et al. 
(2007) makes a strong case for the 
precursor cell hypothesis. These lsevier Inc.authors demonstrate that inactiva-
tion of Rb and p130 in the presence 
of only a single p107 allele in the ret-
ina leads to increased proliferation 
of a cell type bearing the character-
istics of horizontal cells and located 
at the outer edge of the retina’s inner 
nuclear layer. DNA synthesis and 
mitotic activity is observed in cells 
expressing markers specific for hor-
izontal cells. Furthermore, cell bod-
ies with condensed chromosomes 
(presumably undergoing mitosis) 
form synaptic processes and neu-
ronal extensions called neurites that 
are characteristic of horizontal cells. 
The authors also show examples of 
horizontal cells undergoing cytoki-
nesis while maintaining their charac-
teristic neurites. Subsequently, after 
a brief period of indolence, aggres-
sive metastatic tumors developed 
in which proliferating cells retained 
the characteristics of differentiated 
horizontal interneurons.
The new work has important 
implications. First, it challenges the 
widely held belief that differentia-
tion and proliferation are incompat-
ible processes. Furthermore, the 
new model in which differentiated 
neurons form aggressive metastatic 
tumors doesn’t follow other findings 
that differentiation often inversely 
correlates with tumor aggressive-
ness. Second, these results and 
those of others dispute the pre-
vailing hypothesis that growth of a 
differentiated cell tumor is driven 
by a small compartment of cancer 
stem cells. Loss of pocket proteins 
did not affect the proliferation and 
differentiation of retinal progenitor 
cells, and not a single proliferating 
progenitor cell has been found in 
retinoblastomas of either the ama-
crine or horizontal cell type (Chen et 
al., 2004; Ajioka et al., 2007).
Two key questions that remain 
to be answered are why the inner 
nuclear layer neurons that lack 
pocket proteins stop proliferating 
initially, and what drives them back 
into the cell cycle? An explanation 
may come from Foijer et al. (2005), 
who studied embryonic fibroblasts 
derived from mice lacking pocket 
proteins. In the absence of mito-
figure 1. Retinoblastoma Development in Mice
Loss of pocket proteins allows proliferating progenitor cells in the retina to differentiate into outer and inner nuclear layer precursor cells. These cells 
continue to proliferate at least for a while, but then certain retinal cell types, the rods, cones, ganglion, and bipolar cells die, whereas other retinal 
cells (amacrine, horizontal, and Müller glia cells) survive but become arrested in the cell cycle. A second event that suppresses the p53 pathway 
may alleviate cell-cycle arrest leading to proliferation of differentiated cells.gens, these cells died in large num-
bers. Blocking apoptosis, however, 
did not permit mitogen-independent 
growth; instead, these cells could 
not progress through the cell cycle, 
getting stuck predominantly in the 
G2 phase. Interestingly, G2 arrest was 
reversible and could be alleviated by 
either treatment with mitogens or 
inactivation of the tumor suppressor 
protein p53. Thus, mouse embryonic 
fibroblasts lacking pocket proteins 
and p53 can grow in the absence of 
mitogens, a hallmark of transformed 
cells. From the point of view of the 
retina, these observations suggest 
that pocket-protein-deficient inner 
nuclear layer neurons that are intrin-
sically apoptosis resistant are able 
to proliferate initially but then arrest 
in G2, perhaps because proliferation 
occurs ectopically, i.e., in the inner 
nuclear layer instead of in the outer 
edge of the retina. For clonal expan-
sion and development of retinoblas-
toma, an additional event is required 
that alleviates G2 arrest. Interestingly, 
a recent report shows that abroga-
tion of the p53 pathway by overex-
pression of the p53 inhibitor MDMX 
strongly accelerates retinoblastoma development in mice (Laurie et al., 
2006). This was interpreted to indi-
cate that suppression of apoptosis is 
an essential step in retinoblastoma 
development. However, the data of 
Foijer et al. (2005) leave open the 
possibility that loss of p53 function 
abolishes cell-cycle arrest. Thus, the 
model emerging is that retinoblas-
toma in mice requires two events: (1) 
loss of pocket proteins generating 
an increased pool of differentiated 
inner nuclear layer precursor cells 
in the retina (although with limited 
proliferation capacity) and (2) alle-
viation of cell-cycle arrest leading to 
the formation of a tumor composed 
of proliferating differentiated cells 
(Figure 1).
Is the mouse a good model of 
human retinoblastoma? Although the 
genetics and histopathology of retin-
oblastomas in mice and humans may 
seem different (Nork et al., 1995), it is 
quite possible that the basic mecha-
nisms underlying retinoblastoma 
development are similar. Should this 
be confirmed, mouse models will 
prove valuable for testing new thera-
peutic approaches to defeat this dev-
astating childhood cancer.Cell 131, ORefeRences
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